General Information of Drug (ID: DMPH27Y)

Drug Name
MORAb-28
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
D06SNV

References

1 ClinicalTrials.gov (NCT01212276) A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma. U.S. National Institutes of Health.